A potential new biomarker for predicting future cognitive resilience versus decline among people with early Alzheimer's ...

A newly developed blood test for Alzheimer's disease not only aids in the diagnosis of the neurodegenerative condition but ...

A newly developed blood test for Alzheimer's disease not only aids in the diagnosis of the neurodegenerative condition but ...

US researchers have developed a new blood test that not only aids in the diagnosis of Alzheimer’s disease but also indicates ...

A newly developed blood test for Alzheimer's disease not only aids in the diagnosis of the neurodegenerative condition but also indicates how far it ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the ... ARIA ...

This work provides new opportunities for the development of the next generation of ChE inhibitors that specifically target ...

The EMA has recommended refusing marketing authorization for donanemab, a monoclonal antibody against amyloid beta, in the ...

But there's a catch: New research suggests that those blood tests may be unreliable, especially in Black patients. Doctors ...

In a study of biomarkers in Alzheimer’s dementia, plasma p-tau217 had greater agreement with CSF and amyloid-PET biomarker profiles than did FDG-PET scans.

CervoMed's stock soars 400% on promising dementia drug data. See more on insights, potential concerns, and what it means for ...